482 related articles for article (PubMed ID: 29207176)
1. P4HB and PDIA3 are associated with tumor progression and therapeutic outcome of diffuse gliomas.
Zou H; Wen C; Peng Z; Shao YΥ; Hu L; Li S; Li C; Zhou HH
Oncol Rep; 2018 Feb; 39(2):501-510. PubMed ID: 29207176
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of prolyl 4-hydroxylase, beta polypeptide (P4HB) attenuates temozolomide resistance in malignant glioma via the endoplasmic reticulum stress response (ERSR) pathways.
Sun S; Lee D; Ho AS; Pu JK; Zhang XQ; Lee NP; Day PJ; Lui WM; Fung CF; Leung GK
Neuro Oncol; 2013 May; 15(5):562-77. PubMed ID: 23444257
[TBL] [Abstract][Full Text] [Related]
3. P4HB promotes HCC tumorigenesis through downregulation of GRP78 and subsequent upregulation of epithelial-to-mesenchymal transition.
Xia W; Zhuang J; Wang G; Ni J; Wang J; Ye Y
Oncotarget; 2017 Jan; 8(5):8512-8521. PubMed ID: 28052026
[TBL] [Abstract][Full Text] [Related]
4. PDIA3 correlates with clinical malignant features and immune signature in human gliomas.
Zhang H; Zhou Y; Cheng Q; Dai Z; Wang Z; Liu F; Fan F; Cui B; Cao H
Aging (Albany NY); 2020 Aug; 12(15):15392-15413. PubMed ID: 32687065
[TBL] [Abstract][Full Text] [Related]
5. miR-146b-5p functions as a tumor suppressor by targeting TRAF6 and predicts the prognosis of human gliomas.
Liu J; Xu J; Li H; Sun C; Yu L; Li Y; Shi C; Zhou X; Bian X; Ping Y; Wen Y; Zhao S; Xu H; Ren L; An T; Wang Q; Yu S
Oncotarget; 2015 Oct; 6(30):29129-42. PubMed ID: 26320176
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of P4HB is correlated with poor prognosis in human clear cell renal cell carcinoma.
Zhu Z; He A; Lv T; Xu C; Lin L; Lin J
Cancer Biomark; 2019; 26(4):431-439. PubMed ID: 31640086
[TBL] [Abstract][Full Text] [Related]
7. Identification of P4HA1 as a prognostic biomarker for high-grade gliomas.
Hu WM; Zhang J; Sun SX; Xi SY; Chen ZJ; Jiang XB; Lin FH; Chen ZH; Chen YS; Wang J; Yang QY; Guo CC; Mou YG; Chen ZP; Zeng J; Sai K
Pathol Res Pract; 2017 Nov; 213(11):1365-1369. PubMed ID: 28964577
[TBL] [Abstract][Full Text] [Related]
8. miR-320a functions as a suppressor for gliomas by targeting SND1 and β-catenin, and predicts the prognosis of patients.
Li H; Yu L; Liu J; Bian X; Shi C; Sun C; Zhou X; Wen Y; Hua D; Zhao S; Ren L; An T; Luo W; Wang Q; Yu S
Oncotarget; 2017 Mar; 8(12):19723-19737. PubMed ID: 28160566
[TBL] [Abstract][Full Text] [Related]
9. Collagen Type X Alpha 1 (COL10A1) Contributes to Cell Proliferation, Migration, and Invasion by Targeting Prolyl 4-Hydroxylase Beta Polypeptide (P4HB) in Breast Cancer.
Yang W; Wu X; Zhou F
Med Sci Monit; 2021 Feb; 27():e928919. PubMed ID: 33637669
[TBL] [Abstract][Full Text] [Related]
10. Protein disulfide isomerases are promising targets for predicting the survival and tumor progression in glioma patients.
Peng Z; Chen Y; Cao H; Zou H; Wan X; Zeng W; Liu Y; Hu J; Zhang N; Xia Z; Liu Z; Cheng Q
Aging (Albany NY); 2020 Feb; 12(3):2347-2372. PubMed ID: 32023222
[TBL] [Abstract][Full Text] [Related]
11. Prolyl 4-hydroxylase subunit beta (P4HB) could serve as a prognostic and radiosensitivity biomarker for prostate cancer patients.
Feng D; Li L; Li D; Wu R; Zhu W; Wang J; Ye L; Han P
Eur J Med Res; 2023 Jul; 28(1):245. PubMed ID: 37480146
[TBL] [Abstract][Full Text] [Related]
12. PDIA3 Expression in Glioblastoma Modulates Macrophage/Microglia Pro-Tumor Activation.
Chiavari M; Ciotti GMP; Canonico F; Altieri F; Lacal PM; Graziani G; Navarra P; Lisi L
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33153019
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of microRNA-15b correlates with unfavorable prognosis and malignant progression of human glioma.
Pang C; Guan Y; Zhao K; Chen L; Bao Y; Cui R; Li G; Wang Y
Int J Clin Exp Pathol; 2015; 8(5):4943-52. PubMed ID: 26191187
[TBL] [Abstract][Full Text] [Related]
14. PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients.
Draaisma K; Wijnenga MM; Weenink B; Gao Y; Smid M; Robe P; van den Bent MJ; French PJ
Acta Neuropathol Commun; 2015 Dec; 3():88. PubMed ID: 26699864
[TBL] [Abstract][Full Text] [Related]
15. Protein disulphide isomerase can predict the clinical prognostic value and contribute to malignant progression in gliomas.
Hu Q; Huang K; Tao C; Zhu X
J Cell Mol Med; 2020 May; 24(10):5888-5900. PubMed ID: 32301283
[TBL] [Abstract][Full Text] [Related]
16. Protein Disulfide-Isomerase A3 Is a Robust Prognostic Biomarker for Cancers and Predicts the Immunotherapy Response Effectively.
Tu Z; Ouyang Q; Long X; Wu L; Li J; Zhu X; Huang K
Front Immunol; 2022; 13():837512. PubMed ID: 35401558
[TBL] [Abstract][Full Text] [Related]
17. Assessing the contribution of the two protein disulfide isomerases PDIA1 and PDIA3 to cisplatin resistance.
Kullmann M; Kalayda GV; Hellwig M; Kotz S; Hilger RA; Metzger S; Jaehde U
J Inorg Biochem; 2015 Dec; 153():247-252. PubMed ID: 26364260
[TBL] [Abstract][Full Text] [Related]
18. MiRNA expression profiling in human gliomas: upregulated miR-363 increases cell survival and proliferation.
Conti A; Romeo SG; Cama A; La Torre D; Barresi V; Pezzino G; Tomasello C; Cardali S; Angileri FF; Polito F; Ferlazzo G; Di Giorgio R; Germanò A; Aguennouz M
Tumour Biol; 2016 Oct; 37(10):14035-14048. PubMed ID: 27495233
[TBL] [Abstract][Full Text] [Related]
19. Knockdown ATG4C inhibits gliomas progression and promotes temozolomide chemosensitivity by suppressing autophagic flux.
Wen ZP; Zeng WJ; Chen YH; Li H; Wang JY; Cheng Q; Yu J; Zhou HH; Liu ZZ; Xiao J; Chen XP
J Exp Clin Cancer Res; 2019 Jul; 38(1):298. PubMed ID: 31291988
[TBL] [Abstract][Full Text] [Related]
20. Autophagy-related gene
Xie L; Li H; Zhang L; Ma X; Dang Y; Guo J; Liu J; Ge L; Nan F; Dong H; Yan Z; Guo X
Aging (Albany NY); 2020 Jan; 12(2):1828-1842. PubMed ID: 32003756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
